SCHEMBL5513152

SCHEMBL5513152

C1CCC(COCC2CO2)CC1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.54
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 5/20 0.44
TDP1 Q9NUW8 2/20 0.44
MAPK1 P28482 1/20 0.43
TP53 P04637 2/20 0.42
CYP3A4 P08684 2/20 0.42
SPHK2 Q9NRA0 4/20 0.41
SPHK1 Q9NYA1 4/20 0.41
GBA1 P04062 2/20 0.33
UGCG Q16739 2/20 0.33
GBA2 Q9HCG7 2/20 0.33
CTSL P07711 1/20 0.33
CTSB P07858 1/20 0.33
CTSK P43235 1/20 0.33
LMNA P02545 1/20 0.33
HIF1A Q16665 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12481795 0.88 TSHR (0.61) TSHRSMN1; SMN2ALDH1A1TDP1MAPK1
SCHEMBL15033887 0.88 TSHR (0.61) TSHRSMN1; SMN2ALDH1A1TDP1MAPK1
SCHEMBL4313163 0.88 TSHR (0.61) TSHRSMN1; SMN2ALDH1A1TDP1MAPK1
SCHEMBL49884 0.88 TSHR (0.61) TSHRSMN1; SMN2ALDH1A1TDP1MAPK1
SCHEMBL1127982 0.88 TSHR (0.61) TSHRSMN1; SMN2ALDH1A1TDP1MAPK1
SCHEMBL15268272 0.88 TSHR (0.61) TSHRSMN1; SMN2ALDH1A1TDP1MAPK1
SCHEMBL13810709 0.88
SCHEMBL15383241 0.88
SCHEMBL2510810 0.87 TSHR (0.50) TSHRSMN1; SMN2ALDH1A1TDP1MAPK1
Cyclohexane SCHEMBL960269 0.85 TSHR (0.62) TSHRSMN1; SMN2ALDH1A1TDP1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109384921-B Polyimide precursor composition and method for producing polyimide film using same 东进世美肯株式会社 2023-07-18 CN claimed
CN-109384922-B Polyimide precursor composition and method for producing polyimide film using same 东进世美肯株式会社 2023-07-14 CN claimed
CN-1136250-C Crosslinked solid polyelectrolytes and their use ������������ʽ���� 2004-01-28 CN claimed
CN-1215416-A Crss-linked solid polyelectrolyte and use thereof DAISO CO LTD (JP) 1999-04-28 CN claimed
EP-3638705-B1 INTRAOCULAR LENS COMPOSITIONS ALCON INC (CH) 2024-02-28 EP disclosed
CN-110027766-B Applicator for die cut pieces and method and die cut piece strip for applying die cut pieces to a surface 德莎欧洲股份公司 2023-09-05 CN disclosed
CN-113166594-B Potentially reactive adhesive film 德莎欧洲股份公司 2023-08-01 CN disclosed
CN-109384921-B Polyimide precursor composition and method for producing polyimide film using same 东进世美肯株式会社 2023-07-18 CN disclosed
CN-109384922-B Polyimide precursor composition and method for producing polyimide film using same 东进世美肯株式会社 2023-07-14 CN disclosed
US-11642217-B2 Intraocular lens compositions ALCON INC. (CH) 2023-05-09 US disclosed
CN-111491795-B Packaging film 株式会社LG化学 2023-01-10 CN disclosed
CN-110657145-B Applicator for die-cut pieces and method for applying die-cut pieces to a surface and a strip of die-cut pieces 德莎欧洲股份公司 2022-04-05 CN disclosed
US-20020099220-A1 Calcilytic compounds NPS PHARMACEUTICALS, INC. 2002-07-25 US disclosed
EP-0764506-B1 PROCESS FOR PRODUCING MULTI-LAYER MOLDED ARTICLES ARACO KK (JP) 2002-01-02 EP disclosed
US-6022894-A Method of using calcilytic compounds NPS PHARMACEUTICALS, INC. (US) 2000-02-08 US disclosed
US-5961902-A Manufacturing method for molded multilayer article ARACO KABUSHIKI KAISHA (JP) 1999-10-05 US disclosed
EP-0901459-A1 CALCILYTIC COMPOUNDS NPS PHARMACEUTICALS, INC. (US) 1999-03-17 EP disclosed
US-5712342-A Process for producing a water-dispersion of polyurethane resin and a paint composition containing the resin produced by that process KOREA CHEMICAL CO., LTD. (KR) 1998-01-27 US disclosed
WO-1997037967-A1 CALCILYTIC COMPOUNDS NPS PHARMACEUTICALS, INC. (US) 1997-10-16 WO disclosed
EP-0764506-A1 PROCESS FOR PRODUCING MULTI-LAYER MOLDED ARTICLES ARACO KABUSHIKI KAISHA (JP) 1997-03-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020099220-A1 Calcilytic compounds CALCR, CASR, CALCRL TSHR 953/4885SMN1; SMN2 4117/4885ALDH1A1 4285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.